MainReads
← Details
Overall survival after relapse in high-risk neuroblastoma: an adjusted indirect comparison of post-relapse dinutuximab beta, historical controls, and relapse after first-line dinutuximab beta maintenance.
Lode HN, Holko P, Wieczorek A, Śladowska K, Siebert N, Valteau-Couanet D, Garaventa A, Cañete A, Anderson J, Yaniv I, Ash S, Moreno L, Gray J, Luksch R, Laureys G, Owens C, Manzitti C, Troschke-Meurer S, Kawalec P, Ladenstein RL
/
-
Loading document from repository...
Unable to Display Document
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.